MedTrace Logo

Southeast Asian Women's Health Project

NCT04086771 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 194

Last updated 2025-01-16

No results posted yet for this study

Summary

Cancer is the leading cause of death for Southeast Asian refugee and immigrant (R/I) women; yet they have unacceptably low screening rates. Drawing on successful tailored navigation interventions, the purpose of this study is to compare a culturally congruent, tailored navigation intervention delivered by bilingual and bicultural Community Health Advisors (CHAs) to increase age-appropriate breast and cervical cancer screening completion among intergenerational Southeast Asian R/I women (mother-daughter dyads) with information and reminder only. We will examine the underlying factors that associate with the intervention that influence cancer screening completion. We will also explore the influence of intergenerational exchange of breast and cervical cancer screening information between mothers and daughters. This multi-faceted intervention, combining culturally tailored messages and navigation via CHAs, has high potential for scalability across settings and diseases for hard-to-reach populations. In addition, this study focuses on breast and cervical cancer screening jointly potentially increasing the public health impact.

Conditions

Interventions

BEHAVIORAL

Navigation

Weekly phone-calls, personal messages, and American Cancer Society Pap test and mammography test reminder post card

OTHER

Information only

American Cancer Society breast and cervical cancer screening information and Pap test and mammography test reminder post card

Sponsors & Collaborators

  • University of South Florida

    collaborator OTHER

  • American Cancer Society, Inc.

    collaborator OTHER

  • Ohio State University

    lead OTHER

Principal Investigators

  • Jennifer Kue, PhD · University of South Florida

  • Judith Tate, PhD, RN · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-16
Primary Completion
2024-08-30
Completion
2024-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04086771 on ClinicalTrials.gov